Valuation: BillionToOne, Inc.

Market Cap 4.62B 4.15B 3.88B 3.51B 6.59B 440B 6.64B 46.51B 18.16B 228B 17.34B 16.96B 734B P/E 2026 *
126x
P/E 2027 * 97.5x
Enterprise Value 5.09B 4.58B 4.27B 3.87B 7.27B 485B 7.32B 51.28B 20.02B 252B 19.12B 18.7B 809B EV / Sales 2026 *
11.2x
EV / Sales 2027 * 9.1x
Free-Float
74.31%
Yield 2026 *
-
Yield 2027 * -
1 day+3.64%
1 week+2.22%
Current month-8.04%
1 month-2.92%
3 months-21.61%
6 months+18.23%
Current year+19.60%
1 week 90.48
Extreme 90.48
100.31
1 month 90.48
Extreme 90.48
127.72
Current year 61.96
Extreme 61.96
150.44
1 year 61.96
Extreme 61.96
150.44
3 years 61.96
Extreme 61.96
150.44
5 years 61.96
Extreme 61.96
150.44
10 years 61.96
Extreme 61.96
150.44
Manager TitleAgeSince
President 36 2015-12-31
Chief Executive Officer 37 2015-12-31
Director of Finance/CFO 62 2023-12-31
Director TitleAgeSince
Chairman 37 2015-12-31
Director/Board Member 36 2015-12-31
Director/Board Member 62 2019-02-28
Date Insider Type Main position Quantity % Market Cap. Importance
10/8/26 Exercice

Compliance Officer

16,000 0.0375%
10/5/26 Exercice

Founder

60,000 0.1407%
10/5/26 Sell

Executive/Senior Manager

-2,834 0.0066%
Change 5-day change 1-year change 3-year change Capi.($)
+3.64%+2.22% - - 4.62B
-2.01%-7.86%+60.74%+70.97% 68.92B
+0.19%+5.95%+6.56%+59.06% 51.9B
+2.44%+6.46%+11.74%+40.77% 48.73B
+0.51%+1.51%+27.96%+31.43% 43.13B
+2.70%-3.66%+307.41%+547.01% 41.48B
+0.69%-3.44%+9.52%+96.59% 39.96B
+0.06%-2.02%+11.25%+43.27% 30.6B
-2.21%-10.09%+35.34%-0.73% 26.01B
-0.39%-6.92%-13.60%-14.40% 22.27B
Average +0.56%-3.90%+50.77%+97.11% 37.76B
Weighted average by Cap. +0.28%-4.20%+54.68%+104.11%

Financials

2026 *2027 *
Net sales 455M 409M 382M 346M 649M 43.28B 653M 4.58B 1.79B 22.46B 1.71B 1.67B 72.24B 574M 516M 481M 436M 819M 54.6B 824M 5.78B 2.26B 28.34B 2.15B 2.11B 91.14B
Net income 42.86M 38.53M 35.96M 32.59M 61.19M 4.08B 61.57M 432M 168M 2.12B 161M 157M 6.81B 59.89M 53.85M 50.25M 45.55M 85.51M 5.7B 86.04M 603M 235M 2.96B 225M 220M 9.51B
Net Debt 474M 426M 397M 360M 676M 45.07B 680M 4.77B 1.86B 23.39B 1.78B 1.74B 75.24B 604M 543M 506M 459M 862M 57.44B 867M 6.08B 2.37B 29.81B 2.27B 2.22B 95.88B
Projected Income Statement - Annual - BillionToOne, Inc.
Logo BillionToOne, Inc.
BillionToOne, Inc. is a precision diagnostics company that quantifies biology to create molecular diagnostics. The Company's proprietary molecular counting platform is designed to detect and measure deoxyribonucleic acid (DNA) molecules at a single-count level to help improve disease detection. It applies the proprietary technology to non-invasive prenatal screening (Prenatal) and liquid biopsy (Oncology). Its Quantitative Counting Templates (QCTs), power its ability to detect and measure tiny and sparse disease-related DNA fragments, or molecules, at the single base-pair level. These include pregnancy-related DNA that code for recessively inherited conditions such as sickle cell disease and cystic fibrosis and ctDNA in the case of cancer. Its prenatal products include UNITY Complete, UNITY Fetal Risk Screen, UNITY Aneuploidy Screen, UNITY Fetal RhD NIPT, UNITY Fetal Antigen NIPT, and UNITY Fetal Antigen CTA NIPT. Its oncology products include Northstar and Northstar Select.
Employees
713
Date Price Change Volume
26-10-14 US$97.88 +3.64% 424,933
26-10-13 US$94.44 +1.47% 664,221
26-10-12 US$93.07 -5.12% 491,517
26-10-09 US$98.09 +2.81% 325,044
26-10-08 US$95.41 -0.36% 386,304
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - BillionToOne, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
97.88USD
Average target price
129.00USD
Spread / Average Target
+31.79%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - BillionToOne, Inc.
  1. Stock Market
  2. Stocks
  3. BLLN Stock